NIH Delivers $4.3 Million to Support Convalescent Plasma Clinical Trial

August 18, 2020—(BRONX, NY)—As the search for COVID-19 therapies continues, convalescent plasma—distilled from the blood of people who have recovered from COVID-19—has emerged as a promising treatment option. Now, the National Institutes of Health has awarded Albert Einstein College of Medicine and Montefiore a $4.3 million grant to support a randomized, double-blind, placebo-controlled phase 2 clinical trial that launched in April to evaluate the efficacy of convalescent plasma to treat COVID-19.
Source: Einstein News - Category: Universities & Medical Training Source Type: news